In Toronto on June 17, 2026, Satellos Bioscience Inc. (ticker symbols: NASDAQ: MSLE, TSX: MSCL), a biotech firm focusing on treatments for degenerative muscle ailments, unveiled the outcomes of its Annual Shareholder Meeting conducted on the same day.